FDA approves wider use of Lap-Band

The FDA allows Allergan to market the weight loss device to people with a body mass index as low as 30 and with at least one weight-related medical condition.The Food and Drug Administration has approved marketing the Lap-Band weight-loss surgery to patients who are significantly less obese than those who now use the device, according to an announcement Wednesday by its maker, Irvine-based Allergan Inc.

Read the whole article on LA Times - Science

More from LA Times - Science